Skip to main content
MedPathMedPath Home
Clinical Trials/ISRCTN28387915
ISRCTN28387915
Completed
未知

tility of continuous glucose monitoring (CGMS) in children with type I diabetes on intensive treatment regimens

Institute of Endocrinology and Diabetes, The Children's Hospital at Westmead0 sites35 target enrollmentFebruary 9, 2005
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsDiabetesNutritional, Metabolic, Endocrine

Overview

Phase
未知
Intervention
Not specified
Conditions
Diabetes
Sponsor
Institute of Endocrinology and Diabetes, The Children's Hospital at Westmead
Enrollment
35
Status
Completed
Last Updated
6 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

Results in http://www.ncbi.nlm.nih.gov/pubmed/16801571

Registry
who.int
Start Date
February 9, 2005
End Date
September 30, 2004
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Institute of Endocrinology and Diabetes, The Children's Hospital at Westmead

Eligibility Criteria

Inclusion Criteria

  • •Children and adolescents aged 18 years or less with type one diabetes on either an insulin pump or an intensive insulin plan that includes insulin glargine (Lantus) for at least 3 months.

Exclusion Criteria

  • •1\. Known poor compliance
  • •2\. HbA1c greater than 10%

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Use of Continuous Glucose Monitoring System With Intensive Feedback in Adolescents With Poorly Controlled Type 1 DiabetesType 1 Diabetes
NCT03020069NYU Langone Health13
Completed
Phase 4
Continuous Glucose Monitoring System (CGMS) in Type 2 Diabetic Patients Inadequately Controlled by Metformine Monotherapy; Analyze of Glycemic Profile Before and After Association of GlimepirideDiabetes Mellitus
NCT00633425Sanofi43
Completed
Not Applicable
Effect of Continuous Glucose Monitoring on Course of Glucose in Type 1 DiabetesType 1 DiabetesHypoglycemia
NCT00467688Forschungsinstitut der Diabetes Akademie Mergentheim50
Completed
Not Applicable
Efficacy of Continuous Glucose Monitoring in Subjects With Type 1 Diabetes Mellitus on Multiple Daily Injections (MDI) or Continuous Subcutaneous Insulin Infusion (CSII) TherapyType 1 Diabetes Mellitus
NCT01104142DexCom, Inc.120
Completed
Not Applicable
Continuous glucose monitoring (CGM) in advanced neurodegenerative diseasesneurodegenerative diseases0
JPRN-jRCT1090220372ational Health Organization Hyogo-Chuo National Hospital10